Skip to main content
Premium Trial:

Request an Annual Quote

Dionex Posts 13 Percent Increase in Q1 Revenues, 31 Percent Jump in HPLC Sales

Premium

Chromatography systems vendor Dionex posted revenues of $102.9 million for the first quarter of its fiscal year 2011, a 13 percent increase over last year's first-quarter figure of $90.7 million driven in part by a 31 percent increase in sales of its HPLC devices.

In a statement, Dionex CEO Frank Whitney noted that HPLC sales were particularly strong in the Asia-Pacific market, and that the company had seen increased demand from its life science customers compared to the first quarter of 2010.

He projected 2011 sales in the range of $452 million to $460 million based on improving economic conditions and the recent release of products, including Dionex's new UHPLC+ line.

The company posted profits of $10.9 million for the quarter, up 6 percent over $10.3 million in the first quarter of 2010.

It spent $8 million on R&D, up 11 percent from $7.1 million a year ago, and reported holdings of $77 million in cash and cash equivalents.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.